For the first time since the state began regulating medical marijuana last year, a recall of infused products has been announced.

The marijuana-infused products, including transdermal patches and tinctures made by Choice Labs of Jackson and sold under the brand name of Mary’s, are not necessarily dangerous. They just got into the medical marijuana market without being tested.

“The products went through the tracking system and made it to dispensaries,” said David Harns, spokesman for the state Department of Licensing and Regulatory Affairs. “The processor has the ability to retrieve the product, test it and put it back into the tracking system or destroy it.”

More than a dozen medical marijuana dispensaries around the state were carrying the line of products when the state discovered that they hadn’t been tested. Patients with the products should return them to the dispensaries where they were purchased.

The dispensaries have lists of patients who bought the products and the state is encouraging the owners to call patients to let them know about the recall.

More:Start low, go slow with marijuana edibles

More:Legendary pot advocate John Sinclair opening cafe in Detroit

Products affected by the recall, which carry the Processor License number of PR-000005, are:

Mary's Transdermal Indica Patches

The Remedy Tincture-Mary's

Mary's Transdermal Patches CBD

The Coltyn 1:1 Tincture

Mary's Transdermal 1:1 Patches

Patches and tinctures are used by patients who are looking for pain relief, but who don't want to or can't necessarily tolerate smoking marijuana.

It's the first recall since the state handed out the first medical marijuana business license in August. Since then, marijuana products have been relatively scarce as growers rush to cultivate and test product for the 52 licensed dispensaries around the state.

The state has instituted a seed-to-sale tracking system, which begins with growers and tracks products — both marijuana flower and infused products — through processing, testing, transport and their final destination at the dispensaries.

The system is bound to get more complicated when recreational marijuana, which was approved by voters during the 2018 general election, hits the commercial market in early 2020.

Contact Kathleen Gray: 313-223-4430, kgray99@freepress.com or on Twitter @michpoligal.